| Volume: | 1,164,239 |
|---|---|
| Day's Low: | $40.94 |
| 52-wk Low: | $27.15 |
| Previous Close: | $41.47 |
| Dividend: | $0.49 |
| Market Cap: | 117,387,400 |
| Avg Volume: | 1,453,800 |
|---|---|
| Day's High: | $41.56 |
| 52-wk High: | $42.18 |
| Open Price: | $40.95 |
| Yield: | 4.73% |
| P/E (Forward): | 10.55 |
| 1:46 PM | 11/20/2009 | CDC: Sees Slight Decline In H1N1 Influenza Illnesses |
| 1:39 PM | 11/20/2009 | WHO: Mutated H1N1 Virus In Norway Sensitive To Antiviral Drugs |
| 8:34 AM | 11/20/2009 | EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix |
| 5:26 AM | 11/19/2009 | Swiss Health Body Expands Use Of Swine-Flu Vaccine Pandemrix |
| 4:54 PM | 11/18/2009 | UPDATE: FDA Panel Votes Against Approving Xolair In Children |
| 12:22 PM | 11/18/2009 | FDA Panel Questions Dosing Levels For Novartis's Xolair |
| 6:31 AM | 11/16/2009 | GlaxoSmithKline, Nabi Biopharmactuticals In Licensing Pact |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.93 | NA | NA |
| EPS, GAAP | 0.00 | 0.71 | NA |
| Consensus Estimate | 0.96 | NA | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | NA | 3.79 | NA |
| EPS, GAAP | 1.65 | 3.45 | -52.17 |
| Consensus Estimate | NA | NA | NA |
| GSK | Industry Average | |
| P/E (TTM) | 25.13 | 16.80 |
| P/E (Forward) | 10.55 | 1.10 |
| PEG Ratio | 2.56 | 0.07 |
| Price/Sales | 4.28 | 3.05 |
| Beta | 0.63 | 0.66 |